EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte Studie

Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron‐Overloaded Thalassemia Patients

Pokpong Piriyakhuntorn, Adisak Tantiworawit, Mattabhorn Phimphilai, Tawika Kaewchur, Piangrawee Niprapan, Bhumrapee Srivichit, Nattayaporn Apaijai, Krekwit Shinlapawittayatorn, Nipon Chattipakorn, Siriporn C Chattipakorn

Journal of Pineal Research · 2025-04 · 77 (3)

DOI: 10.1111/jpi.70055 ↗

At a glance

Randomisierte kontrollierte Studie in Journal of Pineal Research, published online on 2025-05-06. Written by Pokpong Piriyakhuntorn and 9 co-authors. Institution: Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Major MEDLINE topics: Melatonin, Oxidative Stress, Bone Density, Thalassemia. Cited 8 times so far (Crossref); 52 references. Funded by: This research was supported by Fundamental Fund 2022, Chiang Mai University (Grant number FF65/040), a research grant from the Faculty of Medicine, Chiang Mai….

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Thalassemia patients often exhibit low bone mineral density (BMD). The iron overload associated with thalassemia elevates oxidative stress levels, leading to reduced BMD. Melatonin improves BMD in postmenopausal osteopenia, however, its effect on BMD in thalassemia patients with iron overload has not been investigated. A randomized controlled study was conducted at Hematology Clinic, Faculty of Medicine, Chiang Mai University. Thalassemia patients with osteopenia and iron overloaded condition, as indicated by BMD Z‐score 500 μg/L were recruited in this study. Patients were randomized to receive either melatonin 20 mg/day or placebo at bedtime for 12 months. BMD was re‐evaluated 12 months after interventions. Bone turnover markers (BTM), malondialdehyde (MDA as an oxidative stress marker), and pain scores were assessed at baseline, 6, and 12 months. The outcomes, including BMD, BTM, MDA, and pain scores, were evaluated in all patients. Forty‐one thalassemia patients (18 males) were enrolled in the study and randomly assigned to either the melatonin group ( n = 21) or the placebo group ( n = 20). Characteristics of patients were not differences between groups. Mean age was 30.8 ± 6.2 years old. Thirty‐three patients (80.4%) were transfusion‐dependent patients. At 12 months, mean BMD at l ‐spine in melatonin group was not significantly different from placebo group ( p = 0.069). However, l ‐spine BMD at 12 months in the melatonin group was significantly greater than baseline ( p = 0.029). Serum levels of P1NP and MDA were significantly reduced at 6 months compared to baseline following melatonin treatment. The melatonin group experienced a notable decrease in back pain scores after 12 months compared to the initial measurements. 20 mg daily melatonin supplementation for 12 months alleviated l ‐spine BMD loss in iron‐overloaded thalassemia with low BMD. Melatonin also significantly reduced circulating oxidative stress and mitigated back pain in these patients.

Subjects

MeSH terms (MEDLINE)

MelatoninOxidative StressBone DensityThalassemiaIron OverloadHumansFemaleMaleAdultDietary Supplements

Author keywords

bone mineral densityiron overloadmelatoninosteoporosisoxidative stressthalassemia

Substances

Melatonin

Authors and institutions

  • Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Endocrinology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Oral Surgery, Faculty of Dentistry, Chiang Mai University, Chiang Mai, Thailand.

Funding

  • This research was supported by Fundamental Fund 2022, Chiang Mai University (Grant number FF65/040), a research grant from the Faculty of Medicine, Chiang Mai…

Cite

APA

Piriyakhuntorn, P., Tantiworawit, A., Phimphilai, M., Kaewchur, T., Niprapan, P., Srivichit, B., Apaijai, N., Shinlapawittayatorn, K., Chattipakorn, N., & Chattipakorn, S. C. (2025). Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron‐Overloaded Thalassemia Patients. Journal of Pineal Research, 77(3). https://doi.org/10.1111/jpi.70055

Vancouver

Piriyakhuntorn P, Tantiworawit A, Phimphilai M, Kaewchur T, Niprapan P, Srivichit B, et al. Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron‐Overloaded Thalassemia Patients. Journal of Pineal Research. 2025;77(3). doi:10.1111/jpi.70055

BibTeX
@article{Piriyakhuntorn2025,
  author = {Piriyakhuntorn, Pokpong and Tantiworawit, Adisak and Phimphilai, Mattabhorn and Kaewchur, Tawika and Niprapan, Piangrawee and Srivichit, Bhumrapee and Apaijai, Nattayaporn and Shinlapawittayatorn, Krekwit and Chattipakorn, Nipon and Chattipakorn, Siriporn C},
  title = {Melatonin Supplementation Alleviates Bone Mineral Density Decline and Circulating Oxidative Stress in Iron‐Overloaded Thalassemia Patients},
  journal = {Journal of Pineal Research},
  year = {2025},
  volume = {77},
  number = {3},
  doi = {10.1111/jpi.70055}
}
Start for free →